Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N6QB
|
||||
| Former ID |
DIB000438
|
||||
| Drug Name |
MT-112
|
||||
| Synonyms |
BiTE antibody (solid tumor), Micromet/Bayer
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [549000] | ||
| Company |
Amgenl; bayer healthcare pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Glutamate carboxypeptidase II | Target Info | [543445] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| TNFalpha Signaling Pathway | |||||
| WikiPathways | One Carbon Metabolism | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

